GC Biopharma and Speragen Sponsored an Externally Led - Patient Focused Drug Development with FDA Attendance ...Middle East

PR Newswire - News
GC Biopharma and Speragen Sponsored an Externally Led - Patient Focused Drug Development with FDA Attendance
YONGIN, South Korea and AUSTIN, Texas, Aug. 30 2022 /PRNewswire/ -- GC Biopharma (006280.KS) and Speragen today announced that a joint Externally Led - Patient-Focused Drug Development (EL-PFDD) meeting hosted by SSADH Association and attended by the U.S. FDA and other stakeholders was...

Hence then, the article about gc biopharma and speragen sponsored an externally led patient focused drug development with fda attendance was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( GC Biopharma and Speragen Sponsored an Externally Led - Patient Focused Drug Development with FDA Attendance )

Apple Storegoogle play

Last updated :

Also on site :



Latest News